Candidiasis in interferon-γ knockout (IFN-γ(-/-)) mice

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 478-487

  Balish, Edward ^a   Wagner, R Doug ^b   Vázquez Torres, Andrés ^c   Pierson, Carey ^d   Warner, Thomas ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; HELPER CELL; HOST RESISTANCE; HOST SUSCEPTIBILITY; IMMUNE DEFICIENCY; IMMUNOREACTIVITY; INTERFERON PRODUCTION; INTESTINE MUCOSA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH MUCOSA;

EID: 0031823640     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515645     Document Type: Article

References (23)

1. Dupont B, Denning DW, Marriott D, Sugar A, Viviani MA, Sirisanthana T. Mycoses in AIDS patients. J Med Vet Mycol 1993;32(suppl 1):65-77.
2. Samaranayake LP. Host factors and candidosis. In: Samaranayake LP, MacFarlane IW, eds. Oral candidosis. London: Wright, Butterworth and Co, 1996:65-9.
3. Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995;21:897-904.
4. Guiot HFL, Fibbe WE, Van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:524-32.
5. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29:19-24.
6. Maksymiuk AW, Thongprasert S, Hopper P, Lune M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984;72:20-7.
7. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992;14(suppl 1):S120-5.
8. Pfaller MA. Epidemiology of fungal infections: the promise of molecular typing. Clin Infect Dis 1995;20:1535-9.
9. Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996;2(suppl 2):S89-94.
10. Walsh TJ, Hiemenz J, Pizzo PA. Evolving risk factors for invasive fungal infections - all neutropenic patients are not the same. Clin Infect Dis 1994;18:793-8.
11. Wenzel RP. Nosocomical candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-4.
12. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985;6:131-3.
13. Ashman RB, Papadimitriou JM. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 1995;59:646-72.
14. Marodi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB Jr. Enhancement of macrophage candidacidal activity by interferon-γ. Increased phagocytosis, killing and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 1993;91:2596-601.
15. Menacci A, Cenci E, Spaceapilo R, et al. Rationale for cytokine and anticytokine therapy of Candida albicans infections. J Mycol Med 1995;5:25-30.
16. Stevenhagen A, van Forth R. Interferon-γ activates the oxidative killing of Candida albicans by human granulocytes. Clin Exp Immunol 1993;91:170-5.
17. Vázquez-Torres A, Balish E. Macrophages in resistance to candidiasis. Microbiol Molec Biol Rev 1997;61:170-92.
18. Romani L, Howard D. Mechanisms of resistance to fungal infections. Curr Opin Immunol 1995;7:517-23.
19. Romani L, Mencacci A, Tonnetti L, et al. Interleukin-12 but not interferon-γ production correlates with induction of T-helper type 1 phenotype in murine candidiasis. J Immunol 1994;24:909-15.
20. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-409.
21. Vázquez-Torres A, Jones-Carson J, Balish E. Candidacidal activity of macrophages from immunocompetent and congenially immunodeficient mice. J Infect Dis 1994;170:180-8.
22. Vâzquez-Torres A, Jones-Carson J, Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect Immun 1995;63:1142-4.
23. Vazquez-Torres A, Jones-Carson J, Balish E. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. J Infect Dis 1996;170:180-8.